Vitoc Vlad bought 39,600 shares of MAIA Biotechnology, Inc. at $1.00 for $39.6k on Nov 16, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Chief Executive Officer
Chief Executive Officer
Filed Nov 17, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$39,600Shares × reported price
Shares traded
39,600Common Stock
Price per share
$1.00Reported price. Read footnotes for ranges.
% of reported position traded
3.57%This security and ownership context
Holdings after
1,149,121Direct
Trade date
Nov 16, 2026Buy
Filed
Nov 17, 2026, 4:05 PM ET1-day reporting delay
Accession
0001878313-26-000104Code P · Transaction 403006
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 1,109,521 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 13, 2026Buy60,400$1.00$60,400Trade 403005
2 transaction rows in this filing. Joint filers share the same rows.

MAIA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MAIA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago 0%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9905 to $1.0000, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F2: These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.